Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pharma

Functional links between metabolic, cardiovascular and renal diseases, as well as focus on digital and personalized approach to shape diabetes drug development in 2020, says GlobalData

As 2019 draws to a close, Valentina Gburcik, PhD, Senior Director of Cardiovascular and Metabolic Disorders, as well as Gender Health and Digital Teams at leading data and analytics company GlobalData, looks at the key trends that will shape the metabolic disorders pharmaceutical space in 2020, focusing on the most prevalent metabolic disorder of all, […]
Read more

UHC Act, regulatory tax reforms will open new opportunities for Indian pharma industry in Philippines, says GlobalData

The introduction of the Universal Health Care (UHC) Act coupled with business and corporate tax regulatory reforms in the Philippines is likely to open up new avenues for the Indian pharma industry, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines’, reveals that the pharmaceutical market […]
Read more

Rising nursing home population in APAC likely to increase spread of respiratory syncytial virus in elderly, says GlobalData

Respiratory syncytial virus (RSV), a common respiratory infection in children, has increasingly been identified as a leading cause of respiratory disease in the elderly. Continuing rates of aging and increased access to community living in long-term care facilities may increase the spread of RSV among the elderly across the Asia-Pacific (*APAC) region, according to GlobalData, […]
Read more

Case for Orchard Therapeutics’ gene therapy gets stronger with receipt of accelerated assessment from EMA, says GlobalData

Following the news that European Medicines Agency (EMA) granted accelerated assessment of OTL-200; Vinie Varkey, Senior Analyst of Neurology and Ophthalmology at GlobalData, a leading data and analytics company, offers her view on the implications of this trial for the MLD market: “With Orchard Therapeutics’ OTL-200 receiving the accelerated assessment, it is now more likely […]
Read more

Personalized medicines may improve identification of optimal treatment but access to these treatments may be difficult, says GlobalData

‘Personalized medicine’ and ‘precision medicine’ are both defined as using a patient’s genomic and phenotypic data to find targeted therapies. These therapies use a proactive approach, increase patient stratification and targeting, and aim to improve outcomes for healthcare players, according to GlobalData, a leading data and analytics company. GlobalData’s latest thematic report, ‘The State of Personalized/Precision […]
Read more

CPhI Worldwide Frankfurt to feature contributions from Fiona Barry, Peter Shapiro and Bonnie Bain from GlobalData

This year’s CPhI Worldwide pharma event in Frankfurt, Germany, will take place from 5-7 November 2019. It will feature presentations by Bonnie (Bornadata) Bain, Global Head and Executive Vice-President of Healthcare Operations & Strategy at GlobalData, alongside Fiona Barry and Peter Shapiro, Editors at PharmSource, a GlobalData product. Bonnie Bain, Global Head and Executive Vice-President of Healthcare Operations and Strategy, GlobalData […]
Read more

Hope for cancer patients, as the development of immuno-oncology therapies continues to grow globally according to Cancer Research Institute study leveraging data from GlobalData

The number of immuno-oncology (IO) therapies in clinical development and volume of clinical investigations testing these therapies for the treatment of cancer patients continue to grow, and will undoubtedly fulfill unmet needs in both hematological cancers and solid tumors over the next five to ten years. Leveraging data from GlobalData’s Pharma Intelligence platform, an Immuno-oncology Landscape update from […]
Read more

Gene therapy development expected to pick up pace, says GlobalData

Ongoing collaborations between different industry players and a buildup of real-world evidence establishing safety and efficacy are expected to drive the growth of gene therapies for neurology indications. Data and analytics company GlobalData’s latest report, ‘Gene Therapy in Neurology’, highlights that, of the 38 pipelines products that are currently in development, 45% are adeno-associated virus […]
Read more
1 … 102 103 104 105 106 … 108